Skip to content
DataLookout
Menu

NCT06470035

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)

StatusWithdrawn
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Stopped Withdrawn before enrolling Sponsor's reason: The study was withdrawn prior to initiation. No participants were enrolled. Show 5 more changesShow less
    • Enrollment target: estimated 170 to confirmed 0
    • Start date: Apr 2025 to Jan 6, 2027
    • Eligibility criteria expanded, about 40 words
    • Secondary endpoints: details revised at 5 of 5 entries
    • Site contacts updated at 2 of 2 sites
  2. Minor Study sites revised (2)v4
  3. Notable Primary and study completion dates: Dec 2025 to Apr 2027
    • Start date: Jan 2025 to Apr 2025
    v3
  4. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Hamilton Depression Rating Scale (HDRS-17)
Timeframe: Change in score from baseline to 6 weeks

Secondary (4)

WHO Disability Assessment Schedule 2.0 (WHODAS2)
Insomnia Severity Index (ISI)
Quality of Life (EQ-5D-5L)
Hamilton Depression Rating Scale (HDRS-17)

Arms and interventions

Active VeNSExperimental

The active device utilizes a technology termed vestibular nerve stimulation (VeNS). The device will be placed on the head in a manner analogous to headphones and will deliver a small electrical current to the skin behind the ears, over the mastoid processes. Participants will be advised to use the device at home for 30 minutes per day.

Sham VeNSSham comparator

The sham device looks identical to the active device and interacts with the app in a similar manner to the active device. The device will be placed on the head in a manner analogous to headphones with hydrogel electrodes placed over the mastoid processes. Participants will be advised to use the device at home for 30 minutes per day.

Devices: Active VeNS Device, Sham VeNS Device

Sites

2 sites in 2 countries

United Kingdom 1, United States 1